Literature DB >> 29500011

Individual dose-response models for levodopa infusion dose optimization.

Ilias Thomas1, Moudud Alam2, Dag Nyholm3, Marina Senek3, Jerker Westin2.   

Abstract

BACKGROUND AND
OBJECTIVE: To achieve optimal effect with continuous infusion treatment in Parkinson's disease (PD), the individual doses (morning dose and continuous infusion rate) are titrated by trained medical personnel. This study describes an algorithmic method to derive optimized dosing suggestions for infusion treatment of PD, by fitting individual dose-response models. The feasibility of the proposed method was investigated using patient chart data.
METHODS: Patient records were collected at Uppsala University hospital which provided dosing information and dose-response evaluations. Mathematical optimization was used to fit individual patient models using the records' information, by minimizing an objective function. The individual models were passed to a dose optimization algorithm, which derived an optimized dosing suggestion for each patient model.
RESULTS: Using data from a single day's admission the algorithm showed great ability to fit appropriate individual patient models and derive optimized doses. The infusion rate dosing suggestions had 0.88 correlation and 10% absolute mean relative error compared to the optimal doses as determined by the hospital's treating team. The morning dose suggestions were consistency lower that the optimal morning doses, which could be attributed to different dosing strategies and/or lack of on-off evaluations in the morning.
CONCLUSION: The proposed method showed promise and could be applied in clinical practice, to provide the hospital personnel with additional information when making dose adjustment decisions.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Algorithmic dosing suggestions; Levodopa infusion; Parkinson’s disease; Patient-specific models

Mesh:

Substances:

Year:  2018        PMID: 29500011     DOI: 10.1016/j.ijmedinf.2018.01.018

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  2 in total

1.  Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.

Authors:  Zhang Ping; Wu Xiaomu; Xie Xufang; Shao Liang
Journal:  Neurol Sci       Date:  2018-10-12       Impact factor: 3.307

2.  Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson's Disease.

Authors:  Murshid Saqlain; Moudud Alam; Lars Rönnegård; Jerker Westin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-02       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.